Pneumonia: all 2,072 studies
Page 10 of 21. Open to participants first (286), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia PatientsCompletedNCT04673162Phase 3
- Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19)CompletedNCT04664010Not applicable
- Predictive Value of Ariscat Index In The Development of Pulmonary Complication After Major Abdominal Cancer SurgeryCompletedNCT04663958
- The Impact of Air Pollution on the Consumption of Antimicrobials in the General PopulationStatus unknownNCT04662047
- Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAPTerminatedNCT04660084Not applicable
- A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired PneumoniaTerminatedNCT04659122Phase 1
- Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and ColchicineCompletedNCT04654416
- Corticosteroids in Community Acquired PneumoniaWithdrawnNCT04652414Phase 2
- Diagnostic Accuracy of Infection Biomarkers in the Initial Investigation of Patients With Suspected PneumoniaCompletedNCT04652167
- The Effect of a Point-of-care Sputum Specimen Assay at the Emergency Department for Patients Suspected of PneumoniaCompletedNCT04651712Not applicable
- Effects of Fuzheng Huayu Tablets on COVID-19CompletedNCT04645407Phase 4
- The Value of Ultralow Dosis CT and Ultrasound in the Diagnosing of Pneumonia in the Emergency DepartmentCompletedNCT04645030
- Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent TracheostomyStatus unknownNCT04642703
- Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 PneumoniaStatus unknownNCT04642040Not applicable
- Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)CompletedNCT04636671Phase 3
- Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/SepticemiaNo longer availableNCT04636554
- Aerosolized Colistin to Mechanical Ventilated Patients With PneumoniaCompletedNCT04633317Not applicable
- Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer PatientsStatus unknownNCT04632342Phase 2
- Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 SubjectsCompletedNCT04629703Phase 3
- A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 PneumoniaCompletedNCT04623021Phase 2
- plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU PatientsStatus unknownNCT04622826Phase 2
- Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.CompletedNCT04621058Phase 3
- Use of Reticulocyte Ratio and Neutrophil / Lymphocyte Ratio in the Diagnosis of Ventilator-associated PneumoniaCompletedNCT04620941
- Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 PneumoniaTerminatedNCT04619693
- Surfactant Protein D Levels in Covid-19 Infection: Case-Control StudyCompletedNCT04618861
- FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 PneumoniaCompletedNCT04618042Phase 2
- Inhaled NO for the Treatment of Viral Pneumonia in AdultsCompletedNCT04606407Not applicable
- Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated PneumoniaStatus unknownNCT04602442Phase 2
- Long-term Follow-up Findings of Inpatients for COVID-19 PneumoniaCompletedNCT04599998
- Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive InfectionStatus unknownNCT04594785
- Myeloid Cells in Patients With Covid-19 PneumoniaWithdrawnNCT04590261Not applicable
- Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical CareStatus unknownNCT04589936Not applicable
- D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 PneumoniaStatus unknownNCT04584580Phase 4
- Inflammatory Signal Inhibitors for COVID-19 (MATIS)CompletedNCT04581954Phase 1/2
- Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or LymphopeniaCompletedNCT04578210Phase 1/2
- Comparative Study Between CPAP Mask and Stacked Breathing o PneumoniaCompletedNCT04576221Not applicable
- A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory FailureWithdrawnNCT04574869Phase 1
- Low Dose Lung Radiotherapy to Treat COVID-19 PneumoniaCompletedNCT04572412Not applicable
- Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19CompletedNCT04570254Not applicable
- GM-CSF Inhalation to Prevent ARDS in COVID-19 PneumoniaCompletedNCT04569877Phase 2
- Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICUCompletedNCT04569266Not applicable
- Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia PatientsCompletedNCT04565379Phase 2
- Lung Ultrasound in Procalcitonin- Guided Antibiotic Discontinuation in Ventilator Associated PneumoniaCompletedNCT04563104
- Pulmonary Rehabilitation in Patients With Chronic Fibrotic Hypersensitivity PneumonitisStatus unknownNCT04561479Not applicable
- Nitazoxanide Therapy for Patients With COVID-19 PneumoniaCompletedNCT04561219Phase 2
- Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 PneumoniaWithdrawnNCT04561180Phase 2
- Evaluation of a COVID-19 Pneumonia CXR AI Detection AlgorithmStatus unknownNCT04561024
- Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19CompletedNCT04550325Phase 1/2
- Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 PneumoniaCompletedNCT04542044
- Ultra-low Dose Chest Computed Tomography: a Rule-out Tool for Community-acquired PneumoniaCompletedNCT04541160
- Cyclosporine A Plus Low-steroid Treatment in COVID-19 PneumoniaStatus unknownNCT04540926Phase 1/2
- A Retrospective Study Investigating the Factors Related to Non-tuberculous Mycobacterial Pulmonary Disease in Hong KongStatus unknownNCT04538898
- Convalescent Plasma as Potential Therapy for Severe COVID-19 PneumoniaCompletedNCT04535063Phase 3
- Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 PneumoniaCompletedNCT04534790Not applicable
- Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19Status unknownNCT04534478Phase 4
- Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Nosocomial PneumoniaStatus unknownNCT04531332Not applicable
- Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19Status unknownNCT04530578Phase 4
- Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 InfectionStatus unknownNCT04528888Phase 3
- Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory SupportStatus unknownNCT04528368Phase 2
- Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 PneumoniaCompletedNCT04527354Phase 2
- Reducing the Incidence of VAP in Critically Ill Children and Assessment of Oral Care With CHXCompletedNCT04527276Not applicable
- Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 PneumoniaStatus unknownNCT04527224Phase 1/2
- LLLT Treatment of Lung Inflammation in COVID-19WithdrawnNCT04524715Not applicable
- An Exploratory Study of ADR-001 in Patients with Severe Pneumonia Caused by SARS-CoV-2 InfectionCompletedNCT04522986Phase 1
- Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired PneumoniaActive, not recruitingNCT04522076
- Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" StudyCompletedNCT04517123Not applicable
- Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated DeliriumWithdrawnNCT04513314Phase 4
- Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue FluidStatus unknownNCT04511884
- Comparison Between Positive and Negative COVID-19 PneumoniaCompletedNCT04507893
- Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 PneumoniaTerminatedNCT04505605
- Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring OxygenWithdrawnNCT04502069Phase 1/2
- To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to PneumoniaCompletedNCT04500132Phase 2
- Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex TreatmentCompletedNCT04500067Phase 3
- Online Learning Portal on Under Five PneumoniaCompletedNCT04495361Not applicable
- Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 PneumonitisStatus unknownNCT04493294Phase 1/2
- mHealth for Pneumonia PreventionCompletedNCT04493047Not applicable
- Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19WithdrawnNCT04490486Phase 1
- Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella PneumoniaeStatus unknownNCT04489459Phase 4
- Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:Active, not recruitingNCT04488510
- N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 PneumoniaStatus unknownNCT04487951
- Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 PneumoniaWithdrawnNCT04485429Phase 3
- Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 PneumoniaCompletedNCT04485364
- Eosinophil-guided Reduction of Inhaled CorticosteroidsCompletedNCT04481555Phase 4
- Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University HospitalStatus unknownNCT04481360
- Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831Status unknownNCT04480333Phase 1
- Canakinumab MAP in COVID-19 Pneumonia With CRSNo longer availableNCT04476706
- COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected PatientsStatus unknownNCT04474340Phase 1
- Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance TomographyCompletedNCT04473300
- Tofacitinib in Hospitalized Patients With COVID-19 PneumoniaCompletedNCT04469114Phase 3
- Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical VentilationCompletedNCT04468035
- Low Versus High Corticosteroid Use in Ventilator Associated PneumoniaCompletedNCT04467892Phase 2
- Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) PneumoniaActive, not recruitingNCT04466683Phase 2
- An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 YearsCompletedNCT04464291Not applicable
- Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCsStatus unknownNCT04461925Phase 1/2
- Lanadelumab in Participants Hospitalized With COVID-19 PneumoniaWithdrawnNCT04460105Phase 1
- Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 PneumoniaStatus unknownNCT04459676Phase 2
- Characteristics of Patients With COVID-19 in Meta State, ColombiaWithdrawnNCT04456426
- FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 ContextStatus unknownNCT04453540
- Anti Infective Agents Impact in COVID-19 PneumoniaCompletedNCT04453501
- Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate PneumoniaCompletedNCT04453384Phase 2